WallStreetZenWallStreetZen

NASDAQ: AVTE
Aerovate Therapeutics Inc Stock Ownership - Who owns Aerovate Therapeutics?

Insider buying vs selling

Have Aerovate Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Timothy P. NoyesCHIEF EXECUTIVE OFFICER2023-02-0115,000$2.14
$32.10kBuy
Timothy P. NoyesCHIEF EXECUTIVE OFFICER2023-02-0110,505$22.52
$236.58kSell
Timothy P. NoyesCHIEF EXECUTIVE OFFICER2023-02-014,495$23.05
$103.61kSell
Benjamin T. DakeOfficer Title President Chief Operating Officer and Secretary2023-01-067,492$25.62
$191.95kSell
Benjamin T. DakeOfficer Title President Chief Operating Officer and Secretary2023-01-067,871$2.14
$16.84kBuy
Benjamin T. DakeOfficer Title President Chief Operating Officer and Secretary2023-01-062,413$1.74
$4.20kBuy
Benjamin T. DakeOfficer Title President Chief Operating Officer and Secretary2023-01-062,792$26.95
$75.25kSell
Ralph NivenCHIEF SCIENTIFIC OFFICER2023-01-052,250$26.40
$59.40kSell
Ralph NivenCHIEF SCIENTIFIC OFFICER2023-01-051,600$2.14
$3.42kBuy
Ralph NivenCHIEF SCIENTIFIC OFFICER2023-01-05650$1.74
$1.13kBuy

1 of 15

AVTE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVTE insiders and whales buy or sell their stock.

AVTE Shareholders

What type of owners hold Aerovate Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP33.59%8,263,982$202.55MInstitution
Sofinnova Investments Inc15.28%3,758,686$92.13MInstitution
Maha Katabi15.28%3,758,686$92.13MInsider
Sofinnova Venture Partners X LP15.28%3,758,686$92.13MInsider
David S. Grayzel12.61%3,103,879$76.08MInsider
Cormorant Asset Management LP9.47%2,330,691$57.13MInstitution
Atlas Venture Fund Xii LP9.46%2,327,909$57.06MInsider
Atlas Venture Life Science Advisors LLC9.46%2,327,909$57.06MInstitution
Cormorant Asset Management LP8.25%2,030,691$49.77MInsider
Baker Bros Advisors LP8.05%1,979,568$48.52MInstitution

1 of 3

AVTE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVTE63.46%36.54%Net BuyingNet Buying
ALVR15.68%84.32%Net BuyingNet Selling
ZYME63.52%36.48%Net BuyingNet Buying
ALLK42.64%57.36%Net BuyingNet Selling
NRIX83.59%16.41%Net BuyingNet Selling

Aerovate Therapeutics Stock Ownership FAQ

Who owns Aerovate Therapeutics?

Aerovate Therapeutics (NASDAQ: AVTE) is owned by 109.66% institutional shareholders, 63.14% Aerovate Therapeutics insiders, and 0.00% retail investors. Maha Katabi is the largest individual Aerovate Therapeutics shareholder, owning 3.76M shares representing 15.28% of the company. Maha Katabi's Aerovate Therapeutics shares are currently valued at $92.13M.

If you're new to stock investing, here's how to buy Aerovate Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.